The Biden administration has come out in support of waiving intellectual property protections for coronavirus vaccines, siding with international efforts to bolster production amid concerns about vaccine access in developing nations
A health care worker administers COVID-19 vaccines at California State University in Los Angeles, May 4, 2021. The Biden administration, siding with some world leaders over the U.S. pharmaceutical industry, came out in favor of waiving intellectual property protections for coronavirus vaccines; Image: Allison Zaucha/The New York Times
©2019 New York Times News Service